Compare General Dynamics Corporation (GD) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Dynamics Corporation vs ResMed Inc. — how do they compare? General Dynamics Corporation trades at $391.11 (market cap $106.03B), while ResMed Inc. trades at $220.4 (market cap $32.61B). The key difference: General Dynamics Corporation is far larger — about 3.3× ResMed Inc.'s market cap, and General Dynamics Corporation pays the higher dividend (1.62%). Which is the better fit depends on your goals.
| GD | RMD | |
|---|---|---|
Market Cap | $106.03B | $32.61B |
Sector | Industrials | Health |
52-Week High | $395.97 | $293.73 |
52-Week Low | $312.53 | $182.82 |
Enterprise Value | $111.17B | $31.97B |
Dividend Yield | 1.62% | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About General Dynamics Corporation
General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.
Read more on GD →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
